Hims & Hers Health says it will offer compounded GLP-1 drugs, despite FDA warnings

Hims & Hers Health’s stock jumped nearly 30% Monday after the health and wellness platform said it would offer compounded versions of popular GLP-1 drugs.

For more details: Read More